News
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...
NFL Hall of Famer Randy Moss, a bile duct cancer survivor, is returning to ESPN's NFL coverage after a challenging recovery.
6d
Asianet Newsable on MSNBile Duct Cancer: Symptoms, Diagnosis, and Treatment OptionsVarious tests are used to diagnose bile duct cancer, including liver function tests, tumor markers, ultrasound, CT scan, MRI, ...
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...
5d
News-Medical.Net on MSNCombination therapy sets new survival standard for advanced biliary tract cancerIn a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...
Following an aggressive cancer diagnosis and the end of her marriage, Katie Nicholl finds tranquility at the Oberoi.
One of the greatest wide receivers in the history of the NFL opened up about his return to his television gig after a battle ...
Randy Moss was forced off TV when he was diagnosed with a rare form of cancer, but the legendary wideout's getting ready to ...
Jon Bible, a member of the Collegiate Baseball Hall of Fame, also worked as a football referee in SWC, Big 12 and NFL.
Randy Moss is set to make a full-time return to ‘Sunday NFL Countdown’ following his cancer diagnosis in December 2024. The ESPN analyst was forced to step back from his role with the network ...
5d
MedPage Today on MSNCombo Therapy Boosts Survival in Resectable Biliary Tract CancerCamrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results